Effects of Metreleptin in Type 1 Diabetes Mellitus
This study is currently recruiting participants.
Verified June 2013 by University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
First received: December 29, 2010
Last updated: June 19, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||June 2014|
|Estimated Primary Completion Date:||October 2013 (Final data collection date for primary outcome measure)|